Basel Medical Files F-1 for Up to 6M Units with Zero-Cash Warrants
BMGL is trading near its 52-week low of $3.9 (11% above the low) on light trading volume (0.2× avg).
Summary
Basel Medical Group filed an F-1 to sell up to 6 million units with warrants that could add up to 12 million shares total — a highly dilutive structure for a company with only 1.58 million shares outstanding. The offering is priced at $1.33 per unit, with gross proceeds of $7.98 million and net proceeds of about $7.37 million.
Updated with an SEC F-1/A filing · What changed
Updates
· SEC F-1/A — The offering is priced at $1.33 per unit, with gross proceeds of $7.98 million and net proceeds of about $7.37 million. Placement agent fee is 6% capped at $400,000.
Key Events · Financing and Capital Events · BMGL
-
New · · SEC F-1/A
Placement Agent Fee Capped at $400,000
The placement agent fee is 6% of gross proceeds, capped at $400,000.
-
Updated · · SEC F-1/A
Up to 6M Units Registered at $1.33 Each
Each unit consists of one ordinary share (or pre-funded warrant) and one common warrant to purchase one ordinary share. The offering is priced at $1.33 per unit, with gross proceeds of $7.98 million and net proceeds of about $7.37 million.
-
Zero-Cash Warrant Exercise
Common warrants can be exercised via a zero-cash option, potentially issuing up to 6,000,000 additional shares with no cash proceeds to the company.
-
Potential Share Count Quadrupling
Current outstanding shares are 1,582,111. If all units are sold and all warrants exercised, total shares could reach 13,582,111.
-
Best-Efforts, No Minimum
The offering is best-efforts with no minimum amount required to close, so actual proceeds are uncertain.
Analysis · BMGL · Industrial Applications And Services
Basel Medical Group is registering a best-efforts offering of up to 6 million units, each with one ordinary share (or pre-funded warrant) and one common warrant. The common warrants carry a zero-cash exercise option that could add up to 6 million more shares without any cash coming in — a structure that could nearly quadruple the current 1.58 million share count if fully exercised. The company recently regained Nasdaq compliance after a 1-for-12 reverse split, and this highly dilutive structure risks pushing the stock back below the $1 minimum bid price. The offering has no minimum amount required to close, so actual proceeds are uncertain. The units are priced at $1.33 each, for gross proceeds of $7.98 million and net proceeds of about $7.37 million, with a placement agent fee of 6% capped at $400,000.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.9% of the 1009 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BMGL was trading at $4.31 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.7M. The 52-week trading range was $3.90 to $25.80. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.